Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Little SJ"" wg kryterium: Autor


Tytuł:
Recommendations on data sharing in HIV drug resistance research.
Autorzy:
Inzaule SC; Amsterdam Institute for Global Health and Development, and Department of Global Health, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Siedner MJ; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
Little SJ; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, California, United States of America.
Avila-Rios S; Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Ayitewala A; National Health Laboratories and Diagnostic Services, Ministries of Health, Kampala, Uganda.
Bosch RJ; Center for Biostatistics in AIDS Research, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America.
Calvez V; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France.
Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
Charpentier C; Service de Virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, F-75018 Paris, France.
Descamps D; Service de Virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, F-75018 Paris, France.
Eshleman SH; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Fokam J; Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon, and Faculty of Health Sciences, University of Buea, Yaoundé, Cameroon.
Frenkel LM; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.
Gupta RK; Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, United Kingdom.
Ioannidis JPA; Department of Medicine, Department of Epidemiology and Population Health, and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, United States of America.
Kaleebu P; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Entebbe, Uganda.
Kantor R; Department of Medicine, Brown University, The Miriam Hospital, Providence, Rhode Island, United States of America.
Kassaye SG; Department of Medicine, Division of Infectious Diseases, Georgetown University, Washington DC, United States of America.
Kosakovsky Pond SL; Institute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.
Kouamou V; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Kouyos RD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland and Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Kuritzkes DR; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Lessells R; Affiliation is KwaZulu-Natal Research Innovation & Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa.
Marcelin AG; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France.
Mbuagbaw L; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
Minalga B; Office of HIV/AIDS Network Coordination, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Ndembi N; Institute of Human Virology Nigeria, Herbert Macaulay Way, Abuja, Nigeria.
Neher RA; Biozentrum, University of Basel, Basel, Switzerland.
Paredes R; Department of Infectious Diseases & irsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain.
Pillay D; Division of Infection and Immunity, University College London, London, United Kingdom.
Raizes EG; United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Rhee SY; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California, United States of America.
Richman DD; Center for AIDS Research, Department of Medicine, University of California San Diego, San Diego, California, United States of America.
Ruxrungtham K; School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Sabeti PC; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Schapiro JM; National Hemophilia Center, Sheba Medical Center, Ramat Gan, Israel.
Sirivichayakul S; Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Steegen K; Department of Molecular Medicine and Haematology, National Health Laboratory Service, Johannesburg, South Africa.
Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
van Zyl GU; Division of Medical Virology, Stellenbosch University and National Health Laboratory Service, Cape Town, South Africa.
Vandamme AM; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium.; Center for Global Health And Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
Wensing AMJ; University Medical Center Utrecht, the Netherlands and Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
Wertheim JO; Department of Medicine, University of California San Diego, San Diego, La Jolla, California, United States of America.
Gunthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland and Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Jordan MR; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
Shafer RW; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California, United States of America.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2023 Sep 22; Vol. 20 (9), pp. e1004293. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV-1*/genetics
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
Humans ; Phylogeny ; Drug Resistance, Viral/genetics ; Anti-Retroviral Agents/therapeutic use ; Mutation
Czasopismo naukowe
Tytuł:
Predictors of Human Immunodeficiency Virus Pre-Exposure Prophylaxis (PrEP) Uptake in a Sexual Health Clinic With Rapid PrEP Initiation.
Autorzy:
Wagner GA; Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego, San Diego, California, USA.
Wu KS; Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego, San Diego, California, USA.; Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan.; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Anderson C; Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego, San Diego, California, USA.
Burgi A; Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego, San Diego, California, USA.
Little SJ; Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego, San Diego, California, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Feb 08; Vol. 10 (3), pp. ofad060. Date of Electronic Publication: 2023 Feb 08 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients.
Autorzy:
Aslam S; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, USA.
Liu J; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, USA.
Sigler R; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, USA.
Syed RR; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, USA.
Tu XM; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, USA.
Little SJ; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, USA.
De Gruttola V; Department of Biostatistics, Harvard TH Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2022 Apr; Vol. 24 (2), pp. e13788. Date of Electronic Publication: 2022 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Organ Transplantation*/adverse effects
COVID-19 Vaccines ; Humans ; SARS-CoV-2 ; Transplant Recipients ; Vaccination
Czasopismo naukowe
Tytuł:
Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.
Autorzy:
Aslam S; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California, USA.
Adler E; Division of Cardiology, Department of Medicine, University of California San Diego, La Jolla, California, USA.
Mekeel K; Department of Surgery, University of California San Diego, La Jolla, California, USA.
Little SJ; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Oct; Vol. 23 (5), pp. e13705. Date of Electronic Publication: 2021 Aug 03.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Organ Transplantation*/adverse effects
2019-nCoV Vaccine mRNA-1273 ; COVID-19 Vaccines ; Humans ; SARS-CoV-2 ; Transplant Recipients ; Treatment Outcome ; Vaccination
Czasopismo naukowe
Tytuł:
Incorporating metadata in HIV transmission network reconstruction: A machine learning feasibility assessment.
Autorzy:
Mazrouee S; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, United States.
Little SJ; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, United States.
Wertheim JO; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, United States.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2021 Sep 22; Vol. 17 (9), pp. e1009336. Date of Electronic Publication: 2021 Sep 22 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Machine Learning*
Metadata*
Algorithms ; Cluster Analysis ; Feasibility Studies ; HIV Infections/epidemiology ; HIV Infections/transmission ; Humans
Czasopismo naukowe
Tytuł:
Integrase Strand Transfer Inhibitors Play the Main Role in Greater Weight Gain Among Men With Acute and Early HIV Infection.
Autorzy:
Wu KS; Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Anderson C; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.
Little SJ; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Dec 28; Vol. 8 (1), pp. ofaa619. Date of Electronic Publication: 2020 Dec 28 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
I wanted it as soon as possible: a qualitative exploration of reactions to access to same-day ART start among participants in San Diego's ART-NET project.
Autorzy:
Amico KR; Department of Health Behavior Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Miller J; Department of Health Behavior Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Schairer C; Department of Psychiatry, San Diego School of Medicine, University of California, La Jolla, CA, USA.
Gianella S; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
Little SJ; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
Hoenigl M; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
Pokaż więcej
Źródło:
AIDS care [AIDS Care] 2020 Sep; Vol. 32 (9), pp. 1191-1197. Date of Electronic Publication: 2019 Nov 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/drug therapy
Sexual and Gender Minorities*
Anti-HIV Agents/*therapeutic use
Adult ; CD4 Lymphocyte Count ; Female ; Homosexuality, Male ; Humans ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł:
Primary Incidence of Hepatitis C Virus Infection Among HIV-Infected Men Who Have Sex With Men in San Diego, 2000-2015.
Autorzy:
Chaillon A; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California.
Sun X; Biostatistics Research Center, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California.
Cachay ER; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California.
Looney D; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California.; VA San Diego Healthcare System, San Diego, California.
Wyles D; Division of Infectious Diseases, Denver Health Medical Center, Denver, Colorado.
Garfein RS; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California.
Martin TCS; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California.
Jain S; Biostatistics Research Center, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California.
Mehta SR; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California.; VA San Diego Healthcare System, San Diego, California.
Smith DM; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California.; VA San Diego Healthcare System, San Diego, California.
Little SJ; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California.
Martin NK; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California.; School of Social and Community Medicine, University of Bristol, Bristol, UK.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2019 Apr 03; Vol. 6 (4), pp. ofz160. Date of Electronic Publication: 2019 Apr 03 (Print Publication: 2019).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Attitudes and Preferences Regarding the Use of Rapid Self-Testing for Sexually Transmitted Infections and HIV in San Diego Area Men Who Have Sex With Men.
Autorzy:
Cushman TA; Division of Infectious Diseases, University of Colorado Denver, Aurora, Colorado.
Graves SK; Division of Infectious Diseases, University of California San Diego, San Diego, California.
Little SJ; Division of Infectious Diseases, University of California San Diego, San Diego, California.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2019 Mar 11; Vol. 6 (3), pp. ofz043. Date of Electronic Publication: 2019 Mar 11 (Print Publication: 2019).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate.
Autorzy:
Bobardt M; Department of Immunology & Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
Kuo J; Department of Immunology & Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
Chatterji U; Department of Immunology & Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
Chanda S; Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States of America.
Little SJ; Department of Medicine, University of California, San Diego, California, United States of America.
Wiedemann N; Debiopharm International S.A., Lausanne, Switzerland.
Vuagniaux G; Debiopharm International S.A., Lausanne, Switzerland.
Gallay PA; Department of Immunology & Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Feb 04; Vol. 14 (2), pp. e0211746. Date of Electronic Publication: 2019 Feb 04 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents/*pharmacology
Azocines/*pharmacology
Benzhydryl Compounds/*pharmacology
CD4-Positive T-Lymphocytes/*metabolism
HIV-1/*physiology
Inhibitor of Apoptosis Proteins/*antagonists & inhibitors
Ubiquitin-Protein Ligases/*antagonists & inhibitors
Virus Latency/*drug effects
Animals ; CD4-Positive T-Lymphocytes/pathology ; CD4-Positive T-Lymphocytes/virology ; Female ; Humans ; Inhibitor of Apoptosis Proteins/genetics ; Inhibitor of Apoptosis Proteins/metabolism ; Mice ; NF-kappa B p52 Subunit/genetics ; NF-kappa B p52 Subunit/metabolism ; Signal Transduction/drug effects ; Signal Transduction/genetics ; Transcription Factor RelB/genetics ; Transcription Factor RelB/metabolism ; Ubiquitin-Protein Ligases/genetics ; Ubiquitin-Protein Ligases/metabolism
Czasopismo naukowe
Tytuł:
Evaluation of opt-out inpatient HIV screening at an urban teaching hospital.
Autorzy:
Osorio G; a Division of Infectious Diseases, Department of Medicine , Icahn School of Medicine at Mount Sinai , New York , USA.; b Division of Infectious Diseases, Department of Medicine , University of California San Diego (UCSD) , San Diego , USA.
Hoenigl M; b Division of Infectious Diseases, Department of Medicine , University of California San Diego (UCSD) , San Diego , USA.; c Division of Pulmonology, Department of Internal Medicine , Medical University of Graz , Graz , Austria.; d Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine , Medical University of Graz , Graz , Austria.
Quartarolo J; e Department of Medicine , University of California San Diego (UCSD) , San Diego , USA.
Barger K; f Internal medicine, Scripps HealthCare , La Jolla , USA.
Morris SR; b Division of Infectious Diseases, Department of Medicine , University of California San Diego (UCSD) , San Diego , USA.
Reed SL; b Division of Infectious Diseases, Department of Medicine , University of California San Diego (UCSD) , San Diego , USA.; g Department of Pathology , University of California San Diego (UCSD) , San Diego , USA.
Lee J; h Department of Medicine , Stritch School of Medicine, Loyola University of Chicago , Maywood , USA.
Little SJ; b Division of Infectious Diseases, Department of Medicine , University of California San Diego (UCSD) , San Diego , USA.
Pokaż więcej
Źródło:
AIDS care [AIDS Care] 2017 Aug; Vol. 29 (8), pp. 1014-1018. Date of Electronic Publication: 2017 Jan 23.
Typ publikacji:
Evaluation Study; Journal Article
MeSH Terms:
Emergency Service, Hospital/*statistics & numerical data
HIV Infections/*diagnosis
Inpatients/*statistics & numerical data
Mass Screening/*statistics & numerical data
Patient Acceptance of Health Care/*statistics & numerical data
Adult ; California/epidemiology ; Female ; HIV Infections/epidemiology ; Hospitals, Teaching ; Humans ; Inpatients/psychology ; Male ; Mass Screening/methods ; Middle Aged ; Patient Acceptance of Health Care/psychology ; Prevalence ; Program Evaluation ; Urban Population
Czasopismo naukowe
Tytuł:
Risk profile and HIV testing outcomes of women undergoing community-based testing in San Diego 2008-2014.
Autorzy:
Graves SK; Division of Infectious Diseases, University of California San Diego, San Diego, California, USA.
Little SJ; Division of Infectious Diseases, University of California San Diego, San Diego, California, USA.
Hoenigl M; Division of Infectious Diseases, University of California San Diego, San Diego, California, USA.; Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2017 Feb 06; Vol. 7, pp. 42183. Date of Electronic Publication: 2017 Feb 06.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Risk-Taking*
HIV Infections/*epidemiology
HIV Infections/*ethnology
Unsafe Sex/*statistics & numerical data
Adult ; Black People ; California/epidemiology ; Female ; HIV Infections/diagnosis ; HIV Infections/psychology ; Hispanic or Latino ; Humans ; Incidence ; Male ; Mass Screening/statistics & numerical data ; Middle Aged ; Self Report ; Sexual Partners/psychology ; Unsafe Sex/ethnology ; Unsafe Sex/psychology ; White People
Czasopismo naukowe
Tytuł:
Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations.
Autorzy:
Oliveira MF; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Chaillon A; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Nakazawa M; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Vargas M; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Letendre SL; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.; HIV Neurobehavioral Research Center, San Diego, California, United States of America.
Strain MC; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Ellis RJ; HIV Neurobehavioral Research Center, San Diego, California, United States of America.; Departments of Neurosciences and Psychiatry, University of California San Diego, La Jolla, California, United States of America.
Morris S; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Little SJ; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Smith DM; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.; Veterans Affairs San Diego Healthcare System, San Diego, California, United States of America.
Gianella S; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2017 Jan 03; Vol. 13 (1), pp. e1006112. Date of Electronic Publication: 2017 Jan 03 (Print Publication: 2017).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiretroviral Therapy, Highly Active/*methods
Biomarkers/*cerebrospinal fluid
Central Nervous System/*virology
Cognitive Dysfunction/*virology
DNA, Viral/*blood
DNA, Viral/*cerebrospinal fluid
HIV Infections/*drug therapy
HIV-1/*genetics
Adult ; Biomarkers/blood ; CD4-Positive T-Lymphocytes/virology ; Cognition ; DNA, Viral/genetics ; HIV Infections/pathology ; HIV-1/physiology ; Humans ; Inflammation/drug therapy ; Leukocytes, Mononuclear/cytology ; Male ; Prospective Studies ; RNA, Viral/cerebrospinal fluid ; Secondary Prevention
Czasopismo naukowe
Tytuł:
Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis.
Autorzy:
Hoenigl M; Division of Infectious Diseases, Department of Medicine, University of California San Diego, San Diego, California, United States.; Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Chaillon A; Division of Infectious Diseases, Department of Medicine, University of California San Diego, San Diego, California, United States.
Moore DJ; Department of Psychiatry, University of California San Diego (UCSD), La Jolla, California, United States.
Morris SR; Division of Infectious Diseases, Department of Medicine, University of California San Diego, San Diego, California, United States.
Mehta SR; Division of Infectious Diseases, Department of Medicine, University of California San Diego, San Diego, California, United States.; Veterans Affairs Healthcare System, San Diego, California, United States.
Gianella S; Division of Infectious Diseases, Department of Medicine, University of California San Diego, San Diego, California, United States.
Amico KR; Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Little SJ; Division of Infectious Diseases, Department of Medicine, University of California San Diego, San Diego, California, United States.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 Sep 06; Vol. 6, pp. 32947. Date of Electronic Publication: 2016 Sep 06.
Typ publikacji:
Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiretroviral Therapy, Highly Active*
HIV Infections/*drug therapy
HIV-1/*drug effects
Viral Load/*drug effects
Adult ; Aged ; CD4 Lymphocyte Count ; Female ; Follow-Up Studies ; HIV Infections/diagnosis ; Humans ; Male ; Middle Aged ; Prognosis ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies